Tag: FDA

A total of 115 posts are filed under FDA
Screen Shot 2016-09-19 at 2.45.53 PM
Duchenne Community Rejoices over FDA Approval of Eteplirsen!
CureDuchenne applauds the first-ever approval of a drug in the U.S. to treat Duchenne muscular dystrophy. The drug, Exondys 51… Continue Reading
RARECast: How to Improve Patient Access to Experimental Drugs
  Expanded access—a means by which physicians and patients can obtain experimental drugs outside of a clinical trial—has been an area… Continue Reading
RARE DISEASE REPORT: FDA Approves HAE Drug Berinert For Pediatric Use
The FDA has approved Berinert [C1 Esterase Inhibitor (Human)], to be used in pediatric patients to treat Hereditary Angioedema (HAE)… Continue Reading
Screen Shot 2016-06-16 at 3.52.25 PM
Marathon Pharmaceuticals Announces Submission of Deflazacort New Drug Application to the FDA
Marathon Pharmaceuticals, LLC, a biopharmaceutical company developing treatments for rare diseases, today announced it has submitted a New… Continue Reading
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease
The FDA ended a busy week by giving a thumbs-up late Friday to obeticholic acid as a treatment for primary biliary cirrhosis, a rare… Continue Reading
Keytruda 50mg/vial
Rare Disease Report: FDA Expands Keytruda Indication for Advanced Melanoma
The FDA has approved an expanded indication for Keytruda (pembrolizumab), an anti-PD-1 (programmed death receptor-1) therapy, to include it… Continue Reading
CureDuchenne Responds to FDA Advisory Committee Meeting on Drisapersen for Duchenne Muscular Dystrophy
CureDuchenne, the California-based nonprofit organization dedicated to finding cures for Duchenne muscular dystrophy, released the… Continue Reading